PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Amisulpride
Presentation Product Chemical substance Chapter Items dispensed
Amisulpride 200mg tablets
0402010A0AAAAAA
Amisulpride Amisulpride Central Nervous System 39,371
Amisulpride 100mg tablets
0402010A0AAAGAG
Amisulpride Amisulpride Central Nervous System 30,786
Amisulpride 50mg tablets
0402010A0AAABAB
Amisulpride Amisulpride Central Nervous System 22,428
Amisulpride 400mg tablets
0402010A0AAAEAE
Amisulpride Amisulpride Central Nervous System 12,677
Amisulpride 100mg/ml oral solution sugar free
0402010A0AAAHAH
Amisulpride Amisulpride Central Nervous System 1,269
Solian 100mg/ml oral solution
0402010A0BBAFAH
Solian Amisulpride Central Nervous System 16
Solian 50 tablets
0402010A0BBABAB
Solian Amisulpride Central Nervous System 13
Amisulpride 25mg/5ml oral liquid
0402010A0AAADAD
Amisulpride Amisulpride Central Nervous System 11
Solian 100 tablets
0402010A0BBAEAG
Solian Amisulpride Central Nervous System 11
Solian 400 tablets
0402010A0BBACAE
Solian Amisulpride Central Nervous System 10
Solian 200 tablets
0402010A0BBAAAA
Solian Amisulpride Central Nervous System 7
Amisulpride 12.5mg/5ml oral liquid
0402010A0AAAJAJ
Amisulpride Amisulpride Central Nervous System No data available
Amisulpride 200mg/5ml oral solution
0402010A0AAAMAM
Amisulpride Amisulpride Central Nervous System No data available
Amisulpride 50mg/5ml oral liquid
0402010A0AAACAC
Amisulpride Amisulpride Central Nervous System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.